Clinical Trial Update: Preference Study Between NovoFine® Autocover™ and a NovoFine® 8 mm Needle [Phase 4]

View source ↗

Summary

Phase 4 preference study comparing NovoFine Autocover versus a NovoFine 8 mm needle in diabetes care; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• NovoFine 8 mm Needle
• NovoFine Autocover

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Healthcare Professionals | Phase 4 | Status: COMPLETED